Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
IMNM
#1681
Immunome, Inc.
21.8
6
+1.30%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+1.30%
Monatliche Änderung
-14.81%
6 month change
+119.26%
Jahresänderung
+151.55%
Vorheriger Schlusskurs
21.5
8
Open
21.8
6
Bid
Ask
Low
21.8
6
High
21.8
6
Volumen
116
Märkte
Aktien
Gesundheitswesen
IMNM
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.42 M
86.95 M
87.01 M
87.05 M
91.71 M
—
Valuation ratios
Enterprise value
756.93 M
780.02 M
327.99 M
665.62 M
801.33 M
2.57 B
Price to earnings ratio
-1.8
-2.12
-2.24
-3.2
-4.21
-11.77
Price to sales ratio
25.27
28.46
17.85
26.24
41.87
114.42
Price to cash flow ratio
13.82
5.62
2.87
3.69
4.85
17.03
Price to book ratio
0.75
3.44
0.46
0.68
0.9
5.47
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.18
0.33
0.12
0.15
0.19
0.79
Return on equity %
0.22
0.44
0.14
0.16
0.22
0.96
Return on invested capital %
—
696.35
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
797.88
1 519.88
753.73
654.99
2 243.12
5 171.71
EBITDA margin %
—
—
—
—
—
—
Net margin %
743.84
1 470.03
703.14
611.57
2 143.12
4 927.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.17
4.08
10.49
12.13
8.9
35.6
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.02
0.02
0.02
0.02
0.01
0.07
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.57
0.72
0.67
0.57
0.46
2.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.99
3.71
4
3.08
3.1
13.88
Net current asset value per share
4.05
3.77
4.07
3.19
3.18
14.21
Tangible book value per share
3.57
3.09
3.87
3.09
3
13.05
Working capital per share
3.4
2.85
3.68
2.93
2.82
12.28
Book value per share
3.57
3.09
3.87
3.09
3
13.05
Nachrichten
H.C. Wainwright avvia copertura su Immunome con rating Buy
Immunome stock hits 52-week high at $26.74
Il titolo di Immunome raggiunge il massimo di 52 settimane a $25,32
Immunome stock reaches 52-week high at $25.32
Il CEO di Immunome (IMNM) Siegall acquista azioni per 100.000 dollari
Immunome (IMNM) CEO Siegall buys $100k in shares
Guggenheim conferma il rating Buy sulle azioni Immunome dopo finanziamento di $400M
Guggenheim reiterates Buy rating on Immunome stock following $400M financing
Siegall acquista azioni Immunome (IMNM) per 149.000 dollari
Philip Tsai acquista azioni Immunome per 204.899 dollari
Tsai Philip buys $204,899 in Immunome stock
Immunome: Maintaining "Strong Buy" On Successful RINGSIDE Trial With Varegacestat (IMNM)